Walleye Trading’s Dyne Therapeutics DYN Stock Holding History

Walleye Trading’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,326	Closed	-$218K	–	5157
2023 Q3	$218K	Buy	+24,326	New	+$262K	﹤0.01%	3546

Other funds holding DYN

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Walleye Trading's DYN Position: Q4 2023 in Review

Walleye Trading sold out of Dyne Therapeutics (DYN) in Q4 2023, closing a stake of 24,326 shares — an estimated $218K sold.

Walleye Trading first reported a position in DYN in Q3 2023 and held it in 1 quarter. The position peaked at $218K in Q3 2023. 124 funds tracked by Wall St. Rank hold DYN as of Q4 2023.

Walleye Trading reported no remaining Dyne Therapeutics position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 24,326 Dyne Therapeutics shares in Q4 2023, an estimated $218K.
Walleye Trading first reported a position in Dyne Therapeutics in Q3 2023 and held it in 1 quarter.
Walleye Trading's Dyne Therapeutics position peaked at $218K in Q3 2023.
124 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.